203 related articles for article (PubMed ID: 27345657)
21. Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer.
Davidson SM; Ko HC; Harari PM; Wieland AM; Chen S; Baschnagel AM; Kimple RJ; Witek ME
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):456-465. PubMed ID: 29611770
[TBL] [Abstract][Full Text] [Related]
22. CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin.
Küsters-Vandevelde HV; Van Leeuwen A; Verdijk MA; de Koning MN; Quint WG; Melchers WJ; Ligtenberg MJ; Blokx WA
Int J Cancer; 2010 May; 126(9):2123-32. PubMed ID: 19739123
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of TP53 mutations in oral squamous cell carcinoma with human papilloma virus infection.
Kozomara RJ; Brankovic-Magic MV; Jovic NR; Stosic SM; Magic ZM
Int J Biol Markers; 2007; 22(4):252-7. PubMed ID: 18161655
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of different human papillomavirus types and p53 mutations in laryngeal carcinomas: is there a reciprocal relationship?
Salam M; Rockett J; Morris A
Eur J Surg Oncol; 1995 Jun; 21(3):290-6. PubMed ID: 7781800
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Significance of HPV Status in Laryngeal Squamous Cell Carcinoma: A Large-Population Database Study.
Panuganti BA; Finegersh A; Flagg M; Tu X; Orosco R; Weissbrod PA; Califano J
Otolaryngol Head Neck Surg; 2021 Jul; 165(1):113-121. PubMed ID: 33256521
[TBL] [Abstract][Full Text] [Related]
26. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Langerød A; Zhao H; Borgan Ø; Nesland JM; Bukholm IR; Ikdahl T; Kåresen R; Børresen-Dale AL; Jeffrey SS
Breast Cancer Res; 2007; 9(3):R30. PubMed ID: 17504517
[TBL] [Abstract][Full Text] [Related]
27. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
Alsner J; Sørensen SB; Overgaard J
Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447
[TBL] [Abstract][Full Text] [Related]
28. Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx.
Chernock RD; Wang X; Gao G; Lewis JS; Zhang Q; Thorstad WL; El-Mofty SK
Mod Pathol; 2013 Feb; 26(2):223-31. PubMed ID: 22996374
[TBL] [Abstract][Full Text] [Related]
29. TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.
Wunder JS; Gokgoz N; Parkes R; Bull SB; Eskandarian S; Davis AM; Beauchamp CP; Conrad EU; Grimer RJ; Healey JH; Malkin D; Mangham DC; Rock MJ; Bell RS; Andrulis IL
J Clin Oncol; 2005 Mar; 23(7):1483-90. PubMed ID: 15735124
[TBL] [Abstract][Full Text] [Related]
30. p53 mutation as a prognostic marker in advanced laryngeal carcinoma. Department of Veterans Affairs Laryngeal Cancer Cooperative Study Group.
Bradford CR; Zhu S; Poore J; Fisher SG; Beals TF; Thoraval D; Hanash SM; Carey TE; Wolf GT
Arch Otolaryngol Head Neck Surg; 1997 Jun; 123(6):605-9. PubMed ID: 9193221
[TBL] [Abstract][Full Text] [Related]
31. Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.
Yang L; Wang H; Wang Y; He Z; Chen H; Liang S; He S; Wu S; Song L; Chen Y
Oncotarget; 2016 May; 7(22):31878-91. PubMed ID: 26992242
[TBL] [Abstract][Full Text] [Related]
32. Abnormal expression or mutation of TP53 and HPV in vulvar cancer.
Ngan HY; Cheung AN; Liu SS; Yip PS; Tsao SW
Eur J Cancer; 1999 Mar; 35(3):481-4. PubMed ID: 10448303
[TBL] [Abstract][Full Text] [Related]
33. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A
Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546
[TBL] [Abstract][Full Text] [Related]
34. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
[TBL] [Abstract][Full Text] [Related]
35. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation.
Hughes RT; Beuerlein WJ; O'Neill SS; Porosnicu M; Lycan TW; Waltonen JD; Frizzell BA; Greven KM
Oral Oncol; 2019 Nov; 98():20-27. PubMed ID: 31536842
[TBL] [Abstract][Full Text] [Related]
37. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
38. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
[TBL] [Abstract][Full Text] [Related]
39. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival.
Friesland S; Mellin H; Munck-Wikland E; Nilsson A; Lindholm J; Dalianis T; Lewensohn R
Anticancer Res; 2001; 21(1B):529-34. PubMed ID: 11299799
[TBL] [Abstract][Full Text] [Related]
40. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
